Works matching IS 02683369 AND DT 2001 AND VI 27 AND IP 4

Results: 16

Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 381, doi. 10.1038/sj.bmt.1702784

By:

Vlachos, A;
Federman, N;
Reyes-Haley, C;
Abramson, J;
Lipton, J M

Publication type:

Article

Autotransplants for Hodgkin’s disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 387, doi. 10.1038/sj.bmt.1702796

By:

Lazarus, H. M.;
Loberiza, F. R.;
Zhang, M.-J.;
Armitage, J. O.;
Ballen, K. K.;
Bashey, A.;
Bolwell, B. J.;
Burns, L. J.;
Freytes, C. O.;
Gale, R. P.;
Gibson, J.;
Herzig, R. H.;
LeMaistre, C. F.;
Marks, D.;
Mason, J.;
Miller, A. M.;
Milone, G. A.;
Pavlovsky, S.;
Reece, D. E.;
Rizzo, J. D.

Publication type:

Article

Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 462, doi. 10.1038/sj.bmt.1702790

By:

Johansson, J E;
Ekman, T

Publication type:

Article

Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 397, doi. 10.1038/sj.bmt.1702793

By:

van Besien, K;
Rodriguez, A;
Tomany, S;
Younes, A;
Donato, M;
Sarris, A;
Giralt, S;
Mehra, R;
Andersson, B;
Gajewski, J;
Champlin, R;
Cabanillas, F

Publication type:

Article

Ig heavy chain CDR3 size diversities are similar after conventional peripheral blood and ex vivo expanded hematopoietic cell transplants.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 413, doi. 10.1038/sj.bmt.1702794

By:

Gokmen, E;
Bachier, C;
Raaphorst, F M;
Muller, T;
Armstrong, D;
LeMaistre, C F;
Teale, J M

Publication type:

Article

Autologous stem cell transplantation for clinically aggressive non-Hodgkin’s lymphoma: the role of preparative regimens.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 405, doi. 10.1038/sj.bmt.1702795

By:

Salar, A;
Sierra, J;
Gandarillas, M;
Caballero, M D;
Marín, J;
Lahuerta, J J;
García-Conde, J;
Arranz, R;
León, A;
Zuazu, J;
García-Laraña, J;
López-Guillermo, A;
Sanz, M A;
Grañena, A;
García, J C;
Conde, E

Publication type:

Article

Reconstitution of the CD45RO+ and CD20+ lymphoid marrow population following allogeneic bone marrow transplantation for Ph+ CML.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 425, doi. 10.1038/sj.bmt.1702789

By:

Thiele, J;
Kvasnicka, H M;
Beelen, D W;
Welter, A;
Schneider, S;
Leder, L D;
Schaefer, U W

Publication type:

Article

Transplantation of a fetus with paternal Thy-1+CD34+cells for chronic granulomatous disease.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 355, doi. 10.1038/sj.bmt.1702798

By:

Muench, M O;
Rae, J;
Bárcena, A;
Leemhuis, T;
Farrell, J;
Humeau, L;
Maxwell-Wiggins, J R;
Capper, J;
Mychaliska, G B;
Albanese, C T;
Martin, T;
Tsukamoto, A;
Curnutte, J T;
Harrison, M R

Publication type:

Article

Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 373, doi. 10.1038/sj.bmt.1702799

By:

Das, H;
Imoto, S;
Murayama, T;
Mizuno, I;
Sugimoto, T;
Taniguchi, R;
Toda, K;
Isobe, T;
Nakagawa, T;
Nishimura, R;
Koizumi, T

Publication type:

Article

Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 349

By:

Kröger, N;
Zabelina, T;
Krüger, W;
Renges, H;
Stute, N;
Kabisch, H;
Jaburg, N;
Löliger, C;
Krüll, A;
Zander, A R

Publication type:

Article

A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin’s lymphoma.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 433, doi. 10.1038/sj.bmt.1702804

By:

Endo, T;
Sakai, T;
Fujimoto, K;
Yamamoto, S;
Takashima, H;
Haseyama, Y;
Nishio, M;
Koizumi, K;
Koike, T;
Sawada, K

Publication type:

Article

Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 451, doi. 10.1038/sj.bmt.1702797

By:

Juckett, M B;
Cohen, E P;
Keever-Taylor, C A;
Zheng, Y;
Lawton, C A;
Moulder, J E;
Klein, J

Publication type:

Article

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 437, doi. 10.1038/sj.bmt.1702805

By:

Kanda, Y.;
Mineishi, S.;
Saito, T.;
Seo, S.;
Saito, A.;
Suenaga, K.;
Ohnishi, M.;
Niiya, H.;
Nakai, K.;
Takeuchi, T.;
Kawahigashi, N.;
Shoji, N.;
Ogasawara, T.;
Tanosaki, R.;
Kobayashi, Y.;
Tobinai, K.;
Kami, M.;
Mori, S.;
Suzuki, R.;
Kunitoh, H.

Publication type:

Article

The CD34+CD38neg population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 365, doi. 10.1038/sj.bmt.1702810

By:

Donaldson, C;
Denning-Kendall, P;
Bradley, B;
Hows, J

Publication type:

Article

Corynebacterium jeikeium bacteremia in bone marrow transplant patients with Hickman catheters.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 445, doi. 10.1038/sj.bmt.1702808

By:

Wang, C C;
Mattson, D;
Wald, A

Publication type:

Article

High-efficiency volume reduction of cord blood using pentastarch.

Published in:

Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 457, doi. 10.1038/sj.bmt.1702807

By:

Yang, H;
Acker, J P;
Abley, D;
McGann, L E;
Akabutu, J

Publication type:

Article

Works matching IS 02683369 AND DT 2001 AND VI 27 AND IP 4

Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.

Autotransplants for Hodgkin’s disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings.

Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.

Ig heavy chain CDR3 size diversities are similar after conventional peripheral blood and ex vivo expanded hematopoietic cell transplants.

Autologous stem cell transplantation for clinically aggressive non-Hodgkin’s lymphoma: the role of preparative regimens.

Reconstitution of the CD45RO<sup>+</sup> and CD20<sup>+</sup> lymphoid marrow population following allogeneic bone marrow transplantation for Ph<sup>+</sup> CML.

Transplantation of a fetus with paternal Thy-1<sup>+</sup>CD34<sup>+</sup>cells for chronic granulomatous disease.

Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion.

Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.

A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin’s lymphoma.

Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors.

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.

The CD34<sup>+</sup>CD38<sup>neg</sup> population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function.

Corynebacterium jeikeium bacteremia in bone marrow transplant patients with Hickman catheters.

High-efficiency volume reduction of cord blood using pentastarch.